Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
Akers Biosciences reports 2021 executive compensation
By ExecPay News
Published: October 26, 2022
Akers Biosciences reported fiscal year 2021 executive compensation information on October 26, 2022.
In 2021, four executives at Akers Biosciences received on average a compensation package of $3.4M, a 690% increase compared to previous year.
Adam Kaplin, Chief Scientific Officer, received $5.2M in total, which increased by 1,350% compared to 2020. 93% of Kaplin's compensation, or $4.9M, was in stock awards. Kaplin also received $127K in bonus and $250K in salary.
Christopher Chapman, Chief Medical Officer, received a compensation package of $5.1M, which increased by 1628% compared to previous year. 94% of the compensation package, or $4.9M, was in stock awards.
Paul Rivard, General Counsel, earned $1.8M in 2021, a 953% increase compared to previous year.
Christopher C. Schreiber, Chief Executive Officer, received $1.5M in 2021, which increases by 38% compared to 2020.